Harnett J D, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey P S
Department of Medicine, Memorial University of Newfoundland, St. John's, Canada.
Nephron. 1993;65(2):212-4. doi: 10.1159/000187476.
We assessed the reliability and validity of a formula, based on echocardiographically derived parameters, to calculate left ventricular mass index (LVMI) in a group of 15 chronic hemodialysis patients. All patients had M-mode echocardiography before and after a hemodialysis session. Echocardiograms were interpreted by 2 observers blind to each other's measurements. Interobserver reliability for LVMI was high (r = 0.94, p < 0.0007). LVMI decreased in 11 of 15 patients during dialysis and increased in 4. The mean difference in LVMI between pre- and posthemodialysis was 26.2 +/- 15 g/m2 (p < 0.0001). End-diastolic diameter decreased from 53.5 +/- 5.9 to 49.5 +/- 7.5 mm (p = 0.0016). These data indicate that measurement of LVMI is highly reproducible in hemodialysis patients but that it changes significantly over the course of a hemodialysis session. Its use as an outcome measure in clinical trials in hemodialysis patients should be interpreted with caution.
我们评估了基于超声心动图得出的参数计算左心室质量指数(LVMI)的公式在一组15例慢性血液透析患者中的可靠性和有效性。所有患者在血液透析治疗前后均接受了M型超声心动图检查。超声心动图由两名彼此不知道对方测量结果的观察者解读。LVMI的观察者间可靠性很高(r = 0.94,p < 0.0007)。15例患者中有11例在透析期间LVMI下降,4例上升。血液透析前后LVMI的平均差异为26.2±15 g/m²(p < 0.0001)。舒张末期直径从53.5±5.9 mm降至49.5±7.5 mm(p = 0.0016)。这些数据表明,LVMI的测量在血液透析患者中具有高度可重复性,但在一次血液透析治疗过程中会发生显著变化。在血液透析患者的临床试验中,将其用作结局指标时应谨慎解读。